Biotech companies directory 2026

    Biotech Companies in Kuwait

    Kuwait does not have a home-grown Genentech, and pretending otherwise wastes a partnering cycle: the country’s biotechnology layer is a set of well-funded research institutes, a university health-sciences campus, Ministry hospitals that consume imported biologics, and scientific offices of Gulf and multinational manufacturers.

    Dasman Diabetes Institute, created with Kuwait Foundation for the Advancement of Sciences money, is the institute foreign teams actually visit when the brief is metabolism, genetics or a Kuwaiti cohort. KFAS also stands behind other laboratory and grant programmes that look like a cluster on a slide and like a foundation portfolio in person. Kuwait University’s Health Sciences Center in Jabriya trains physicians and hosts investigator studies. The Kuwait Institute for Scientific Research adds applied laboratories that are not GMP plants. Kuwait Life Sciences Company, a KIA-linked investor, has put capital into regional life-science vehicles rather than into a Kuwaiti drug-substance factory. On the supply side, Julphar, Hikma, Sanofi, Novo Nordisk, Roche and GSK run scientific offices that register and detail insulin, vaccines and monoclonal antibodies into Ministry Central Medical Stores and into Hawally and Salmiya private-hospital pharmacies. The Ministry of Health remains the dominant buyer and the Drug and Food Control authority remains the registrar. This directory is honest about that thinness so a brand or licensing team budgets for research access and importation, not for a local fill-finish joint venture that does not exist.

    Updated September 2026 · Kuwait Ministry of Health — Drug and Food Control and Central Medical Stores (biologics registration and public procurement) as of September 2026 · 16 named accounts

    Request a proposal for KuwaitBrowse the 16 companies

    0

    Kuwaiti commercial drug-substance biologics plants comparable to Julphar or VACSERA

    ~70%

    Expatriate share of the population, which shapes private-hospital use of imported biologics

    1

    Specialist institute most often named on diabetes and genomics protocols (Dasman)

    2014

    Year Dhaman was established as the PPP that will change how insured expatriates receive care, including biologics

    Named accounts

    Top biotechnology companies in Kuwait

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Kuwait Ministry of Health — Drug and Food Control and Central Medical Stores (biologics registration and public procurement) (as of 2026-09-04).
    #CompanyHQ
    01Dasman Diabetes InstituteDasman
    02Kuwait Foundation for the Advancement of Sciences (KFAS)Kuwait City
    03Kuwait University — Health Sciences CenterJabriya
    04Kuwait Institute for Scientific Research (KISR)Kuwait City
    05Kuwait Life Sciences Company (KLSC)Kuwait City
    06Kuwait Cancer Control CenterShuwaikh
    07Ministry of Health — Drug and Food ControlKuwait City
    08Ministry of Health — Central Medical StoresKuwait City
    09Julphar — Kuwait scientific officeKuwait City
    10Hikma — Kuwait officeKuwait City
    11Sanofi KuwaitKuwait City
    12Novo Nordisk KuwaitKuwait City
    13Roche KuwaitKuwait City
    14GSK KuwaitKuwait City
    15Dhaman (Health Assurance Hospitals Company)Kuwait City
    16Dar Al Shifa Hospital — pharmacy and researchHawally

    Primary research

    These are the biotech and innovation accounts we track in Kuwait

    Partnering, licensing or launching a biologic in Kuwait? BioNixus runs KOL, payer and regulator interviews plus hospital-level demand sizing. Proposal within 48 hours.

    Planning research in Kuwait?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top healthcare market research companies in Kuwait (2026)

    How the market is structured

    How research institutes and imported biologics serve Kuwait

    The science sits in institutes; the vials sit in a cold room that started in Europe, the US, India or Ras Al Khaimah. A biologic reaches a Kuwaiti patient after the Ministry’s Drug and Food Control registers the file, usually through a local agent, and after Central Medical Stores awards a Ministry lot or a private hospital pharmacy buys on its own account. Dasman can host a cohort study, a biobank draw or an investigator protocol, and KFAS can write a grant, but neither entity fills a monoclonal antibody. Kuwait University HSC and the Kuwait Cancer Control Center supply the other investigator pools. Dhaman’s new expatriate hospitals will add a third buyer with its own formulary once those sites are fully online, which matters more for insulin and specialty volume than any start-up announcement. AFYA, the retiree private-insurance experiment, was suspended in 2024, so retired citizens are back on Ministry books. Partnering conversations that ask “who is the Kuwaiti manufacturer?” should be redirected to “who is the scientific office, who is the Central Medical Stores winner, and which institute can enrol?” That is the real map.

    Local

    Kuwaiti capital and institutes — KFAS, Dasman, KLSC — that fund research and regional vehicles rather than operate a drug-substance plant.

    • Kuwait Life Sciences Company (KLSC)

    Multinational

    Sanofi, Novo Nordisk, Roche and GSK scientific offices that register and detail the originator biologics Ministry stores and private pharmacies actually dispense.

    • Sanofi Kuwait
    • Novo Nordisk Kuwait
    • Roche Kuwait
    • GSK Kuwait

    Regional

    Julphar and Hikma offices that bring Gulf- and Levant-made insulin and injectables into Kuwait without building a local suite.

    • Julphar — Kuwait scientific office
    • Hikma — Kuwait office

    Incubators, CDMOs & partners

    Ministry Drug and Food Control, Central Medical Stores, Kuwait University HSC, KISR, KCCC and Dhaman — the registrar, the buyer, the campuses and the new expatriate system.

    • Dasman Diabetes Institute
    • Kuwait Foundation for the Advancement of Sciences (KFAS)
    • Kuwait University — Health Sciences Center
    • Kuwait Institute for Scientific Research (KISR)
    • Kuwait Cancer Control Center
    • Ministry of Health — Drug and Food Control
    • Ministry of Health — Central Medical Stores
    • Dhaman (Health Assurance Hospitals Company)
    • Dar Al Shifa Hospital — pharmacy and research

    What is moving

    What is moving biotechnology in Kuwait

    Dasman and KFAS as cohort infrastructure

    A funded diabetes institute and a national foundation beat a fictional start-up when a sponsor needs Kuwaiti samples, genotypes or investigators.

    Dhaman shifting expatriate volume

    As insured foreign workers move into Dhaman hospitals, a new formulary will sit beside Central Medical Stores for insulin and specialty biologics.

    Regional manufacturers at the border

    Julphar’s Ras Al Khaimah insulin and Hikma injectables are a one-border-away supply story that localisation rhetoric in Kuwait still depends on.

    Ministry lots still dominate citizen volume

    Citizens remain on free public care, so Central Medical Stores awards — not a venture round — decide whether a biologic is standard of care.

    BioNixus fieldwork

    How BioNixus studies biotechnology companies in Kuwait

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Kuwait:
    • Clinician and laboratory interviews at Dasman and Kuwait University HSC in Jabriya on cohort studies, sample access and industry protocols.
    • Central Medical Stores lot reconstruction in Kuwait City for insulin, vaccines and oncology biologics, including agent names on the awards.
    • Scientific-office interviews with Julphar, Hikma, Sanofi, Novo Nordisk and Roche teams on registration timelines and private-hospital versus Ministry mix.
    • Formulary discussions at Dar Al Shifa (Hawally) and Al Salam on how imported specialty biologics are stocked for insured expatriates.

    Biotech market research in Kuwait

    Questions

    Frequently Asked Questions

    Is there a Kuwaiti commercial biologics manufacturer?

    Not at the scale of Julphar, VACSERA or a European CDMO. What exists are institutes, a university campus, an investment company and scientific offices. Budget for importation and research access.

    Why include Dasman on a company directory?

    Because it is the operating research organisation that sponsors actually contract with for diabetes and genetics work. KFAS is the funder behind it. Neither is a plant.

    Who registers and who buys?

    Drug and Food Control registers. Central Medical Stores buys for Ministry facilities. Private hospitals and, increasingly, Dhaman buy for insured expatriates. Scientific offices of foreign manufacturers hold the files.

    What happened to AFYA and does it matter for biologics?

    The retiree private-insurance scheme was suspended in 2024 and citizens in that cohort returned to Ministry services. It matters because a private payer for older Kuwaitis disappeared, which sends specialty volume back to Central Medical Stores.

    What research does BioNixus run on biotechnology organisations in Kuwait?

    Institute and clinician interviews at Dasman, KCCC and Kuwait University HSC; Central Medical Stores lot reconstruction for insulin and monoclonal antibodies; and scientific-office mapping of who actually holds the registration for each originator and biosimilar.

    Is this a ranking of Kuwait’s biotechnology industry?

    It cannot be, because there is no deep industry to rank. The names are a fieldwork map of institutes, buyers and regional suppliers that keep appearing in BioNixus Kuwait interviews and in Ministry registers.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Kuwait. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Kuwait Ministry of Health — Drug and Food Control and Central Medical Stores (biologics registration and public procurement), consulted 2026-09-04. Company classification (Local / MNC / Regional / incubators, cdmos & partners) reflects ownership and role in Kuwait, not size.

    • Dasman Diabetes Institute and KFAS public programme descriptions
    • Ministry of Health Drug and Food Control and Central Medical Stores materials
    • Dhaman corporate disclosures; 2024 AFYA suspension notices (KUNA / Ministry statements)
    • BioNixus Kuwait hospital, institute and scientific-office fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need biotech and biologics market data in Kuwait?

    Payer appetite, biosimilar uptake, KOL sentiment and tender exposure — primary research, not desk estimates.

    Planning research in Kuwait?

    Primary research, market access & HEOR. Proposals within 48 hours.